Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
13.07
-0.11 (-0.83%)
Aug 24, 2026, 4:00 PM EDT - Market closed
Korro Bio Stock Forecast
Stock Price Forecast
According to 11 analysts polled by S&P Global, Korro Bio stock has a consensus rating of "Strong Buy" and an average price target of $20.2. The average 1-year stock price forecast is 54.55% higher than the current stock price, while the lowest is $10 (-23.49%) and the highest is $30 (+129.53%).
Price Target: $20.2 (+54.55%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Korro Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 8 | 8 | 8 |
| Buy | 1 | 1 | 2 | 2 | 2 | 2 |
| Hold | 4 | 3 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $15 | Buy | Reiterates | $15 | +14.77% | Aug 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $10 | Hold | Maintains | $10 | -23.49% | Aug 8, 2026 |
Unknown Analyst LifeSci Capital No rating | LifeSci Capital | Buy Maintains $21 | Buy | Maintains | $21 | +60.67% | Aug 7, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $30 | Buy | Maintains | $30 | +129.53% | Aug 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $22 | Buy | Maintains | $22 | +68.32% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
333.33K
from 6.39M
Decreased by -94.79%
Revenue Next Year
1.13M
from 333.33K
Increased by 240.00%
EPS This Year
-5.18
from -8.81
EPS Next Year
-4.46
from -5.18
EPS and Forward PE are based on non-GAAP adjusted numbers.